Results
Celecoxib and diclofenac were similar in their control of joint pain and inflammation.
Gastroduodenal ulcers were detected in:
- 15% of patients taking diclofenac
- 4% of patients taking celecoxib
- p<0.001
The rate of withdrawal for gastrointestinal-related adverse events was:
- 16% of patients taking diclofenac
- 6% of patients taking celecoxib
- p<0.001
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page